Prolactinoma
Prolactinoma is one of the uses associated with cabergoline, the active ingredient in Dostinex. Dostinex is a tablet product available in 0.25 mg and 0.5 mg strengths. Cabergoline is also associated with hyperprolactinaemia. A doctor can advise on whether cabergoline is appropriate for an individual.
Medicine used to treat Prolactinoma
Key points
- Dostinex tablets contain cabergoline.
- Cabergoline is associated with prolactinoma and hyperprolactinaemia.
- Dostinex comes in 0.25 mg and 0.5 mg tablet strengths.
Prolactinoma and hyperprolactinaemia
Prolactinoma is named as a use for cabergoline. Hyperprolactinaemia is named separately. More detail on each condition is available on the prolactinoma and hyperprolactinaemia pages. The cabergoline ingredient page covers the medicine used in Dostinex. If a doctor has used either term, ask them to explain the diagnosis and what it means for you.
Dostinex tablets
Dostinex is a cabergoline tablet. It is supplied in two strengths, 0.25 mg and 0.5 mg, and is associated with prolactinoma and hyperprolactinaemia. Orders are shipped to Malaysia by pharmacy partners in India in discreet packaging.
Safety and supervision
Cabergoline should be used under the guidance of a doctor. Tell your doctor or pharmacist about other medicines you take, including medicines bought without a prescription, and about existing health conditions. Ask your pharmacist to check your medicines before you start. If you notice symptoms that concern you, seek advice. Do not start or stop the medicine without medical advice.
When to seek advice
Speak to a doctor if you have questions about a diagnosis of prolactinoma or hyperprolactinaemia. Ask for help understanding test results, treatment choices and follow-up. Bring a list of your medicines to appointments. If you are already using cabergoline and have concerns, contact your doctor or pharmacist. Do not rely on general information alone for treatment decisions.
Further reading
Last updated